Rank: 23 (Previous rank: N.A.)
CEO: Steven Anderson
Headquarters: Kennesaw, GA
Industry: Health Care
Revenue: $105.1 million
(four quarters to 12/31/08)
Return to investors: 42.7%
(three years to 12/81/08, annualized rate)
CryoLife's primary business is shipping cryopreserved human heart valves for use in transplant operations. It also manufactures BioGlue, a polymer made from cattle blood proteins that has been used in more than 450,000 surgical procedures since 1998.
... What Readers Say
They speak out on the fastest-growing small public companies ...
|Executive||2008 Total Compensation